Advertisement LifeStem signs joint venture agreement with Keller Medical Institute - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

LifeStem signs joint venture agreement with Keller Medical Institute

LifeStem, a wholly owned subsidiary of CalbaTech, has signed a joint venture agreement with Keller Medical Institute or KMI for Keller medical professionals to be trained in the procedures of the Stem Cell Microbank Service.

The training and protocols will allow Keller clinics, including its joint venture weight clinics and dental sites, to market and sell the Stem Cell Microbank Service.

James DeOlden, CEO of LifeStem, said: “This is a very important step forward for LifeStem because of the excellent reputation of Keller Medical. We also anticipate announcing further collection services in the near future.”